nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 29th, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 29th, 2022 11:53AM
|
Aug 29th, 2022 11:53AM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 28th, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 28th, 2022 04:52AM
|
Aug 28th, 2022 04:52AM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 27th, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 27th, 2022 04:11AM
|
Aug 27th, 2022 04:11AM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 25th, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 25th, 2022 08:51AM
|
Aug 25th, 2022 08:51AM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 23rd, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 23rd, 2022 10:44AM
|
Aug 23rd, 2022 10:44AM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 21st, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 21st, 2022 12:28PM
|
Aug 21st, 2022 12:28PM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 20th, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 20th, 2022 02:05PM
|
Aug 20th, 2022 02:05PM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 19th, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 19th, 2022 12:28PM
|
Aug 19th, 2022 12:28PM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 18th, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 18th, 2022 04:12AM
|
Aug 18th, 2022 04:12AM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:drna
|
https://www.indeed.com/cmp/dicerna-pharmaceuticals
|
Aug 17th, 2022 12:00AM
|
Open
|
Dicerna Pharmaceuticals
|
|
Pharmaceutical & Biotechnology
|
At Dicerna, we interfere to silence genes, fight rare diseases, enhance health and advance science. The goal is to leverage our GalXC™ platform and strategic partnerships to get the drug to the patient as quickly as possible. Dicerna is dedicated to our patients and committed to breaking down barriers that slow progress in rare diseases. Dicerna interferes to help patients and change lives.
|
RRv1_25M_100M
|
33 Hayden Ave, Lexington MA 02421
|
Douglas M. Fambrough, Ph.D.
|
|
|
2.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.00
|
3.00
|
2.00
|
3.00
|
2.30
|
1.70
|
2.70
|
|
|
|
|
|
|
|
|
|
Aug 17th, 2022 09:51AM
|
Aug 17th, 2022 09:51AM
|
Dicerna Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|